{"id":47430,"date":"2022-08-18T13:02:07","date_gmt":"2022-08-18T11:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/"},"modified":"2022-08-18T13:02:07","modified_gmt":"2022-08-18T11:02:07","slug":"customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/","title":{"rendered":"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds"},"content":{"rendered":"<div>\n<p>\n<span class=\"bwuline\">Kaiser Foundation Health Plan Ranks Highest among Medicare Advantage Plans<\/span>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/5\/2022100.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/753738\/5\/JDPower_Logo16_Red.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/753738\/21\/JDPower_Logo16_Red.jpg\"><\/a><\/p>\n<p>TROY, Mich&#8211;(BUSINESS WIRE)&#8211;Overall customer satisfaction with Medicare Advantage plans has increased this year, thanks largely to improvements in billing and payments, cost and provider choice. However, according to the J.D. Power 2022 U.S. Medicare Advantage Study,<sup>SM <\/sup>released today, some concerning trends are brewing beneath the surface of those positive headline numbers. Most notably, a majority of Medicare Advantage plan members are saying they do not have enough coverage for mental health and substance use disorder services.\n<\/p>\n<p>\n\u201cMedicare Advantage plans have recognized that the key to improved patient outcomes is building engagement with members, encouraging the use of preventive health services and fostering great relationships with primary care providers who are leading overall care coordination,\u201d said <b>Christopher Lis, managing director, global healthcare intelligence at J.D. Power<\/b>. \u201cWith an estimated 1.7 million<sup>1<\/sup> Medicare beneficiaries living with a diagnosed substance use disorder and one in four<sup>2<\/sup> Medicare beneficiaries living with a mental health condition, there is a big opportunity for Medicare Advantage plans to support more patients and families in need. Older adults have been affected by loneliness and social isolation that increased throughout the pandemic. For some health plans, coverage can be improved. For others, increasing customer understanding of mental health benefits may be the bigger opportunity as beneficiaries might be aware that some coverage is available but may not fully understand which services and medications are covered. But coverage does not always guarantee access, as finding providers who accept Medicare may be a challenge in some areas.\u201d\n<\/p>\n<p>\nFollowing are some of the key findings of the 2022 study:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Overall member satisfaction with Medicare Advantage plans rises:<\/b> Overall customer satisfaction with Medicare Advantage plans is 809 (on a 1,000-point scale), which is up 3 points from 2021 and up 15 points during the past five years.\n<\/li>\n<li>\n<b>Missing the mark on mental health and substance abuse disorder services:<\/b> Just 38% of Medicare Advantage plan members say they have enough coverage for mental health treatment, down from 39% a year ago. Just 27% of members say they have enough coverage for substance use disorder services. These numbers compare with 91% of members who say they have enough coverage for routine diagnostics and 89% who say they have enough coverage for preventive and wellness services.\n<\/li>\n<li>\n<b>Telemedicine usage declines, despite largely positive experiences:<\/b> Just 24% of Medicare Advantage plan members used telemedicine during the past year, down from 35% in 2021. Among those who have used the technology, however, 48% say they are very likely to use it again, an increase of five percentage points from last year.\n<\/li>\n<li>\n<b>Health plan portals still show promise, but breaking inertia is hard: <\/b>A strong majority (82%) of Medicare Advantage members are registered for their health plan\u2019s member portal\u2014up four percentage points from a year ago. However, 14% have registered for the portal but never logged in. Overall customer satisfaction scores are 72 points higher (823) when customers register and log-in to the portal than when they do neither (751).\n<\/li>\n<\/ul>\n<p>\n<b>Study Rankings<\/b>\n<\/p>\n<p>\n<b>Kaiser Foundation Health Plan <\/b>ranks highest in Medicare Advantage plan overall satisfaction, with a score of 844. <b>Humana<\/b> (824) ranks second and <b>Highmark<\/b> (811) ranks third.\n<\/p>\n<p>\nThe study, now in its eighth year, measures member satisfaction with Medicare Advantage plans\u2014also known as Medicare Part C or Part D\u2014based on six factors (in order of importance): coverage and benefits; provider choice; cost; customer service; information and communication; and billing and payment.\n<\/p>\n<p>\nThe 2022 Medicare Advantage Study is based on the responses of 3,094 members of Medicare Advantage plans across the United States. It was fielded from May through July 2022.\n<\/p>\n<p>\nFor more information about the 2022 Medicare Advantage Study, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jdpower.com%2Fbusiness%2Fresource%2Fus-medicare-advantage-study&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.jdpower.com%2Fbusiness%2Fresource%2Fus-medicare-advantage-study&amp;index=1&amp;md5=87a7c65e487969fad69d2f0c9cb57e63\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.jdpower.com\/business\/resource\/us-medicare-advantage-study<\/a>.\n<\/p>\n<p>\nSee the online press release at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.jdpower.com%2Fpr-id%2F2022100&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.jdpower.com%2Fpr-id%2F2022100&amp;index=2&amp;md5=f1168b8c260ea4c981a42ae3cf9b40c3\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/www.jdpower.com\/pr-id\/2022100<\/a>.\n<\/p>\n<p>\n<b>About J.D. Power<\/b>\n<\/p>\n<p>\n<b>J.D. Power<\/b> is a global leader in consumer insights, advisory services and data and analytics. A pioneer in the use of big data, artificial intelligence (AI) and algorithmic modeling capabilities to understand consumer behavior, J.D. Power has been delivering incisive industry intelligence on customer interactions with brands and products for more than 50 years. The world&#8217;s leading businesses across major industries rely on J.D. Power to guide their customer-facing strategies.\n<\/p>\n<p>\nJ.D. Power has offices in North America, Europe and Asia Pacific. To learn more about the company\u2019s business offerings, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jdpower.com%2Fbusiness&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=JDPower.com%2Fbusiness&amp;index=3&amp;md5=a615519a2d9af1cadbc337cd29780c87\" rel=\"nofollow noopener\" shape=\"rect\">JDPower.com\/business<\/a>. The J.D. Power auto shopping tool can be found at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jdpower.com%2F&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=JDPower.com&amp;index=4&amp;md5=f6fb629eb78b8c092754d2b746bb98e6\" rel=\"nofollow noopener\" shape=\"rect\">JDPower.com<\/a>.\n<\/p>\n<p>\n<b>About J.D. Power and Advertising\/Promotional Rules:<\/b> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.jdpower.com%2Fbusiness%2Fabout-us%2Fpress-release-info&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=www.jdpower.com%2Fbusiness%2Fabout-us%2Fpress-release-info&amp;index=5&amp;md5=d22f50f0ee1318f59076be7b1c43bea0\" rel=\"nofollow noopener\" shape=\"rect\">www.jdpower.com\/business\/about-us\/press-release-info<\/a>\n<\/p>\n<p>\n<sup>______________________________<br \/>\n<br \/>1<\/sup> \u201cSubstance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment Barriers,\u201d American Journal of Preventive Medicine, August 2022 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F35331570%2F&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F35331570%2F&amp;index=6&amp;md5=ebae26a88dc39a7c21a95947853d9ab3\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35331570\/<\/a><br \/><sup>2<\/sup> \u201cMedicare\u2019s Mental Health Coverage: How COVID-19 Highlights Gaps and Opportunities for Improvement,\u201d The Commonwealth Fund, July 9, 2020 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.commonwealthfund.org%2Fpublications%2Fissue-briefs%2F2020%2Fjul%2Fmedicare-mental-health-coverage-covid-19-gaps-opportunities&amp;esheet=52816919&amp;newsitemid=20220818005066&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.commonwealthfund.org%2Fpublications%2Fissue-briefs%2F2020%2Fjul%2Fmedicare-mental-health-coverage-covid-19-gaps-opportunities&amp;index=7&amp;md5=282a6110c18908efddf0a25b7f2e1ddf\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2020\/jul\/medicare-mental-health-coverage-covid-19-gaps-opportunities<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Relations Contacts<\/b><br \/>Geno Effler, J.D. Power; West Coast; 714-621-6224; <a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#x6d;&#101;&#x64;&#x69;&#97;&#46;&#x72;&#101;l&#x61;&#x74;&#105;&#x6f;&#x6e;&#115;&#64;&#x6a;&#100;p&#x61;&#x2e;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">m&#101;&#100;&#105;&#x61;&#x2e;&#x72;el&#97;&#116;&#x69;&#x6f;&#x6e;&#x73;&#64;j&#100;&#112;&#x61;&#x2e;&#x63;&#x6f;m<\/a><br \/>John Roderick; East Coast; 631-584-2200; <a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;j&#111;&#x68;&#110;&#x40;j&#114;&#x6f;d&#x65;r&#105;&#x63;k&#x2e;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#106;o&#x68;n&#x40;j&#x72;o&#x64;e&#x72;i&#x63;&#107;&#x2e;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kaiser Foundation Health Plan Ranks Highest among Medicare Advantage Plans TROY, Mich&#8211;(BUSINESS WIRE)&#8211;Overall customer satisfaction with Medicare Advantage plans has increased this year, thanks largely to improvements in billing and payments, cost and provider choice. However, according to the J.D. Power 2022 U.S. Medicare Advantage Study,SM released today, some concerning trends are brewing beneath the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47430","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Kaiser Foundation Health Plan Ranks Highest among Medicare Advantage Plans TROY, Mich&#8211;(BUSINESS WIRE)&#8211;Overall customer satisfaction with Medicare Advantage plans has increased this year, thanks largely to improvements in billing and payments, cost and provider choice. However, according to the J.D. Power 2022 U.S. Medicare Advantage Study,SM released today, some concerning trends are brewing beneath the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-18T11:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds\",\"datePublished\":\"2022-08-18T11:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/\"},\"wordCount\":837,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005066\\\/en\\\/1547042\\\/21\\\/2022100.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/\",\"name\":\"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005066\\\/en\\\/1547042\\\/21\\\/2022100.jpg\",\"datePublished\":\"2022-08-18T11:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005066\\\/en\\\/1547042\\\/21\\\/2022100.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005066\\\/en\\\/1547042\\\/21\\\/2022100.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/","og_locale":"en_US","og_type":"article","og_title":"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds - Pharma Trend","og_description":"Kaiser Foundation Health Plan Ranks Highest among Medicare Advantage Plans TROY, Mich&#8211;(BUSINESS WIRE)&#8211;Overall customer satisfaction with Medicare Advantage plans has increased this year, thanks largely to improvements in billing and payments, cost and provider choice. However, according to the J.D. Power 2022 U.S. Medicare Advantage Study,SM released today, some concerning trends are brewing beneath the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-18T11:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds","datePublished":"2022-08-18T11:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/"},"wordCount":837,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/","url":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/","name":"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg","datePublished":"2022-08-18T11:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220818005066\/en\/1547042\/21\/2022100.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/customers-perceive-shortfall-in-medicare-advantage-plan-coverage-of-mental-health-and-substance-abuse-services-j-d-power-finds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Customers Perceive Shortfall in Medicare Advantage Plan Coverage of Mental Health and Substance Abuse Services, J.D. Power Finds"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47430"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47430\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}